RHKJF:OTC-RHÖN-KLINIKUM Aktiengesellschaft (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 13.85

Change

0.00 (0.00)%

Market Cap

USD 0.82B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Medical Care Facilities

ETFs Containing RHKJF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.29% 69% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.29% 66% D+ 69% C-
Trailing 12 Months  
Capital Gain 0.36% 64% D 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.36% 64% D 51% F
Trailing 5 Years  
Capital Gain -40.78% 66% D+ 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -40.78% 66% D+ 41% F
Average Annual (5 Year Horizon)  
Capital Gain -11.45% N/A N/A 21% F
Dividend Return -11.45% N/A N/A 20% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.96% N/A N/A 97% N/A
Risk Adjusted Return -127.78% N/A N/A 2% F
Market Capitalization 0.82B 81% B- 73% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector